Interferon Nasal Drops for SARS-CoV-2 Infection Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is currently no effective drug for treating or preventing SARS-CoV-2 infection, particularly in healthy individuals, relying mainly on physical barriers like masks and isolation clothing.
Innovation Solution
Administering interferon IFN-α1b nasally in a nasal formulation, which can include buffers and excipients, to inhibit viral replication in nasal epithelial cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If physical barriers like masks and isolation clothing are used for prevention, then infection prevention coverage is provided, but ease of operation and user compliance deteriorate due to discomfort and inconvenience
Solution Approach 1:
The patent replaces mechanical physical barriers (masks, isolation clothing) with a biochemical system (interferon nasal drops) that provides passive immunological protection. The interferon formulation creates an immunological barrier in the nasal cavity without requiring active mechanical intervention or user compliance with wearing procedures.
Solution Approach 2:
The interferon nasal drops provide self-service protection by establishing active immunological defense in the nasal cavity. The body's own immune system, enhanced by interferon, automatically detects and responds to viral invasion without requiring continuous external intervention or user awareness, unlike masks that must be continuously worn and adjusted.
2Reliability
If interferon is administered nasally to prevent SARS-CoV-2 infection, then effectiveness in preventing infection improves, but device complexity and formulation requirements worsen
Solution Approach 1:
The patent optimizes critical formulation parameters including pH (5.0-8.0 to match nasal physiology), interferon concentration (1000-3000000 U/ml for therapeutic effect), and osmolarity to ensure both effectiveness and stability. These parameter optimizations enable the complex biological activity of interferon to be delivered reliably through a relatively simple nasal drop formulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Prevents SARS-CoV-2 infection effectively, reducing infection rates among populations and medical workers, and preventing the spread of the epidemic.
Implementation Method 1
Administering interferon IFN-α1b nasally in a nasal formulation, which can include buffers and excipients, to inhibit viral replication in nasal epithelial cells
Data Source
AI summary
Disclosed are a use of an interferon in preparing a drug for preventing novel coronavirus SARS-CoV-2 infection or a disease COVID-19 caused by the novel coronavirus infection, and a drug for preventing novel coronavirus infection or preventing a disease COVID-19 caused by the novel coronavirus infection.